Sanofi-aventis to decentralise research and development

Wednesday 1 July 2009

Sanofi-aventis has become the latest multinational pharmaceutical company to decentralise its research and development business in order to generate more ideas for new drugs from contact with scientists and entrepreneurs outside the company.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

France